Biotechnology stocks have come under political pressure in the US, but history suggests they will recover strongly, says Biotech Growth manager Sven Borho.
Rising interest rates and gilt yields are weakening shares in many alternative income funds, including UK’s biggest listed social infrastructure company.
Finsbury Growth & Income Trust star manager explains why Hargreaves Lansdown, Rathbones and Schroders remain among his favourite growth stocks despite regulatory pressure on fees.
Investment trust gives fund manager Philip Matthews more freedom to invest in smaller companies as it seeks to revive performance.
Technology stocks have enjoyed a stellar year, but fears of another bubble in the sector are wide of the mark, says top investor Ben Rogoff.
Hipgnosis Songs Fund extends its initial public offer until 1 August to give second big investor time to do due diligence.
Ciaran Mallon's Invesco Income Growth trust has lived up to its name after consistently growing shareholder dividends for two decades.
With 'yield starvation' still afflicting investors, Nick Greenwood of Miton Global Opportunities picks out undervalued investment trusts whose dividends he expects to rise.
Invesco Perpetual Select becomes 26th investment trust to curb fund manager charges this year in response to investor pressure.
Shareholders have overwhelmingly backed investment trust’s proposal to pay dividends from capital and more than double yield to 4.5%.